IRLAB Therapeutics AB (FRA:6IRA) Change In Inventory: €0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6IRA IRLAB Therapeutics AB FRA:6IRA
38 GF Score
Price €0.16
GF Value €0.63
! 5 Warning Signs
View Full Analysis

What is IRLAB Therapeutics AB Change In Inventory?

IRLAB Therapeutics AB FRA:6IRA +3.32% 38 Change In Inventory is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:6IRA with a GF Score™ of 38/100 and a GF Value™ of €0.63. The stock has 5 warning signs investors should review.

IRLAB Therapeutics AB's change in inventory for the quarter that ended in Jun. 2026 was €0.00 Mil. It means IRLAB Therapeutics AB's inventory stayed the same from Mar. 2026 to Jun. 2026 .

IRLAB Therapeutics AB's change in inventory for the fiscal year that ended in Dec. 2025 was €0.00 Mil. It means IRLAB Therapeutics AB's inventory stayed the same from Dec. 2024 to Dec. 2025 .

IRLAB Therapeutics AB's Total Inventories for the quarter that ended in Jun. 2026 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. IRLAB Therapeutics AB's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.00.

IRLAB Therapeutics AB  (FRA:6IRA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

IRLAB Therapeutics AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

IRLAB Therapeutics AB's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 0
=N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

IRLAB Therapeutics AB's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 0.584
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IRLAB Therapeutics AB Change In Inventory Related Terms

IRLAB Therapeutics AB Change In Inventory Historical Data

* Premium members only.

The historical data trend for IRLAB Therapeutics AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IRLAB Therapeutics AB Change In Inventory Chart

IRLAB Therapeutics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IRLAB Therapeutics AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:6IRA
38GF Score
IRLAB Therapeutics AB FRA:6IRA
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IRLAB Therapeutics AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €0.00 Mil mean?
IRLAB Therapeutics AB (FRA:6IRA) has a Change In Inventory of €0.00 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for IRLAB Therapeutics AB and its competitors.
Is IRLAB Therapeutics AB's Change In Inventory too high?
IRLAB Therapeutics AB's current Change In Inventory is €0.00 Mil. Overall, IRLAB Therapeutics AB has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does IRLAB Therapeutics AB's Change In Inventory compare to VRTX and REGN?
IRLAB Therapeutics AB's Change In Inventory of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for IRLAB Therapeutics AB and its competitors. IRLAB Therapeutics AB's current Change In Inventory is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRLAB Therapeutics AB stock overvalued right now?
IRLAB Therapeutics AB (FRA:6IRA) has a current Change In Inventory of €0.00 Mil. The stock's GF Value™ is €0.63, compared to a current price of €0.16 — trading 75.3% below its estimated fair value. The current Change In Inventory is €0.00 Mil. IRLAB Therapeutics AB's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For IRLAB Therapeutics AB (FRA:6IRA), the current Change In Inventory is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IRLAB Therapeutics AB (FRA:6IRA) Overvalued in 2026?

Based on GuruFocus' analysis, IRLAB Therapeutics AB stock appears to be undervalued. The current stock price of €0.16 is trading 75.3% below its estimated GF Value™ of €0.63.

Key valuation signals for FRA:6IRA:

  • Change In Inventory: €0.00 Mil
  • GF Value™: €0.63 vs. price of €0.16 (75.3% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the FRA:6IRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IRLAB Therapeutics AB Business Description

Other Exchanges IRLAB A:Sweden
Address Arvid Wallgren Backe 20, Goteborg, SWE, 413 46
IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds that aims to offer improved clinical benefit for patients with Parkinson's disease. The company's current clinical candidates, mesdopetam (IRL790) and pirepemat (IRL752), both of which have successfully gone through Phase I safety and Phase IIa efficacy proof-of-concept studies, are now in Phase IIb trials.
38GF Score

Get the complete analysis for FRA:6IRA

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.16
Price
€0.63
GF Value